COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 2858: Articles 28571-28580  | Next

Studies of Novel Coronavirus Disease 19 (COVID-19) Pandemic: A Global Analysis of Literature
Tran, B. X., Ha, G. H., Nguyen, L. H., Vu, G. T., Phan, H. T., Le, H. T., Latkin, C. A., Ho, C. S. H., Ho, R. C. M.
10.1101/2020.05.05.20092635 — Posted: 2020-05-08
ProgNet: Covid-19 prognosis using recurrent andconvolutional neural networks
Fakhfakh, M., Bouaziz, B., Gargouri, F., Chaari, L.
10.1101/2020.05.06.20092874 — Posted: 2020-05-08 Discussion: Onsite
The impact of Coronavirus disease 2019 (COVID-19) on health systems and household resources in Africa and South Asia
Davies, N. G., Sweeney, S., Torres-Rueda, S., Bozzani, F., Kitson, N., Barasa, E., Procter, S., Quaife, M., LSHTM Centre for Mathematical Modelling of Infectious Diseases COVID-19 Working Group, , Eggo, R. M., Vassall, A., Jit, M.
10.1101/2020.05.06.20092734 — Posted: 2020-05-08
Whole genome and phylogenetic analysis of SARS-CoV-2 strains from the index and early patients with COVID-19 in Dubai, United Arab Emirates, 29 January to 18 March 2020
Abou Tayoun, A., Loney, T., Khansaheb, H., Ramaswamy, S., Harilal, D., Deesi, Z., Varghese, R., Al Suwaidi, H., Alkhajeh, A., AlDabal, L., Uddin, M., Senok, A., Hamoudi, R., Halwani, R., Hamid, Q., Nowotny, N., Alsheikh-Ali, A.
10.1101/2020.05.06.080606 — Posted: 2020-05-08
SARS-CoV-2 proteins exploit host's genetic and epigenetic mediators for the annexation of key host signaling pathways that confers its immune evasion and disease pathophysiology
Khan, M. A.-A.-K., Islam, A. B. M. M. K.
10.1101/2020.05.06.050260 — Posted: 2020-05-08
Lung biopsy cells transcriptional landscape from COVID-19 patient stratified lung injury in SARS-CoV-2 infection through impaired pulmonary surfactant metabolism
Islam, A. B. M. M. K., Khan, M. A.-A.-K.
10.1101/2020.05.07.082297 — Posted: 2020-05-08
The transcriptomic profiling of COVID-19 compared to SARS, MERS, Ebola, and H1N1
Alsamman, A. M., Zayed, H.
10.1101/2020.05.06.080960 — Posted: 2020-05-08 Discussion: Onsite
Massive Multiplexing Can Deliver a $1 Test for COVID-19
Hebert, P. D., Prosser, S. W., Ivanova, N. V., Zakharov, E. V., Ratnasingham, S.
10.1101/2020.05.05.079400 — Posted: 2020-05-08
Coarse-grained molecular simulations of the binding of the SARS-CoV 2 spike protein RBD to the ACE2 cell receptor
De Sancho, D., Perez-Jimenez, R., Gavira, J. A.
10.1101/2020.05.07.083212 — Posted: 2020-05-08
AI334 and AQ806 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA
Lima, W. C.
10.1101/2020.05.08.084103 — Posted: 2020-05-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).